FT-105

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFT-105
Drug Alias NameBasulinLong-acting basal insulin (Flamel Technologies)NN 1215FT 105
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionProtein tyrosine phosphatase stimulantsOrnithine decarboxylase stimulants
TargetsProtein tyrosine phosphataseOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvadel Legacy Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvadel Legacy Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A